Study Evaluating Rapamune in Patients After Kidney Transplantation

Wyeth

Status: Terminated

Conditions: Renal Transplantation

Treatments: Drug: sirolimus

Study type: Observational

Funder types: Industry

Identifiers

NCT00240214

0468E-100875

Details and patient eligibility

About

The purpose of this study is to obtain data on the effectiveness and safety of Rapamune under everyday conditions

Enrollment: 500 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients having received a renal allograft from a cadaveric or living donor with low or moderate risk of developing acute rejection episodes.

Exclusion criteria

• Contraindications according to Summary of the Product Characteristics (SmPC).

Trial design

500 participants in 1 patient group

1

Description:

sirolimus

Treatment:

Drug: sirolimus